Skip to main content

Hyperprolactinemia

Abstract

In several respects prolactin is unique among anterior pituitary hormones. The primary regulation of prolactin secretion is mediated through hypothalamic inhibition, and the diagnosis of hyperprolactinemia can be established without the use of stimulation or suppression tests. Documenting the presence of hyperprolactinemia is not difficult–the challenge is in identifying the cause of the hormone hypersecretion. With immunoradiometric assays falsely low levels of prolactin are occasionally seen in patients with macroadenomas and very high serum prolactin (the hook effect). Macroprolactin should be suspected when a patient with hyperprolactinemia does not present with typical clinical symptoms, and all hyperprolactinemic sera should be screened for macroprolactin. With prolactinomas, prolactin levels generally parallel tumor size. Prolactin secreting macroadenomas are typically associated with levels that exceed 250 μg/l and may exceed 1,000 μg/l. Large non-functioning adenomas also lead to hyperprolactinemia but levels virtually never exceed 94 μg/l. Acquired and isolated prolactin deficiency is rare.

This is a preview of subscription content, access via your institution.

References

  1. Parker DC, Rossman LG, Vanderlaan EF (1973) Relation of sleep-entrained human prolactin release to REM-NonREM cycles. J Clin Endocrinol Metab 38:646–65132

    Google Scholar 

  2. Sassin JF, Frantz AG, Kapen S, Weitzman ED (1973) The nocturnal rise of human prolactin is dependent upon sleep. J Clin Endocrinol Metab 37:436–440. Medline

    PubMed  CAS  Google Scholar 

  3. Veldhuis JD, Johnson L (1988) Operating characteristics of the hypothalamo-pituitary-gonadal axis in men; circadian, ultradian and pulsatile release of prolactin and its temporal coupling with luteinizing hormone. J Clin Endocrinol Metab 67:116–123. Medline

    PubMed  CAS  Google Scholar 

  4. Quigley ME, Ropert JF (1981) Acute prolactin, release triggered by feeding. J Clin Endocrinol Metab 52:1043–1045. Medline

    PubMed  CAS  Google Scholar 

  5. Carlson HE, Hyman DB, Blitzer MG (1990) Evidence for an intracerebral action of phenylalanine in stimulation of prolactin secretion: interaction of large neutral amino acid. J Clin Endocrinol Metab 70:814–816. Medline

    PubMed  CAS  Google Scholar 

  6. Lee PA, Xenakis T, Winer J et al (1976) Puberty in girls: correlation of serum levels of gonadotropins, prolactin, androgens, estrogens and progestins with physical changes. J Clin Endocrinol Metab 43:775–784. Medline

    PubMed  CAS  Article  Google Scholar 

  7. Blackman MR (1987) Pituitary hormones and aging. Endocrinol Clin N Am 16:981–984

    CAS  Google Scholar 

  8. Iranmesh A, Mulligan T, Veldhuis JD (1998) Mechanism subserving the physiological nocturnal hypoprolactinemia of healthy older men: dual decline in prolactin secretory burst mass and basal release with preservation of pulse duration, frequency and interpulse interval—a general clinical research study. J Clin Endocrinol Metab 999:1083–1090

    Google Scholar 

  9. Vekeman M, Delvoye P, L’Hermite M et al (1977) Serum prolactin levels during the menstrual cycle. J Clin Endocrinol Metab 44:989–993. Medline

    Google Scholar 

  10. Neilly AS, Chard T (1974) Circulating levels of prolactin during the menstrual cycle. Clin Endocrinol (Oxf) 3:105–112. Medline

    Article  Google Scholar 

  11. Tyson JE, Fresen HG (1973) Factors influencing the secretion of human prolactin and growth hormone in menstrual and gestational women. Am J Obstet Gynecol 116:377–387. Medline

    PubMed  CAS  Google Scholar 

  12. Reyniak JV, Wenof M, Aubert JM et al (1980) Incidence of hyperprolactinemia during oral contraceptive therapy. Obstet Gynecol 55:8–11. Medline

    PubMed  CAS  Google Scholar 

  13. Davis JR, Selby C, Jeffcoate WJ (1984) Oral contraceptive agents do not affect serum prolactin in normal women. Clin Endocrinol (Oxf) 20:427–434. Medline

    Article  CAS  Google Scholar 

  14. Urban RJ (1992) Neuroendocrinology of aging in the male and female. Endocrinol Metab Clin North Am 21:921–931. Medline

    PubMed  CAS  Google Scholar 

  15. Reyes FI, Winter JS, Faiman C (1977) Pituitary-ovarian relationships preceding the menopause. A cross-sectional study of serum follicle-stimulated hormone, luteinizing hormone, prolactin, oestradiol and progesterone levels. Am J Obstet Gynecol 129:557–564. Medline

    PubMed  CAS  Google Scholar 

  16. Karunakaran S, Page RCL, Wass JAH (2001) The effect of the menopause on prolactin levels in patients with hyperprolactinaemia. Clin Endocrinol (Oxf) 54:295–300. Medline. doi:10.1046/j.1365-2265.2001.01190.x

    Article  CAS  Google Scholar 

  17. Touraine P, Deneux C, Plu-Bureau G et al (1998) Hormonal replacement therapy in menopausal women with history of hyperprolactinemia. J Endocrinol Invest 21:732–736. Medline

    PubMed  CAS  Google Scholar 

  18. Schlegel W, Petersdorf LI, Junker R et al (1999) The effects of six months of treatment with a low dose of conjugated oestrogens in menopausal women. Clin Endocrinol (Oxf) 51:643–651. Medline. doi:10.1046/j.1365-2265.1999.00857.x

    Article  CAS  Google Scholar 

  19. Bonnar J, Franklin M, Nott PN et al (1975) Effect of breast-feeding on pituitary-ovarian function after childbirth. BMJ 4:82–84. Medline

    PubMed  CAS  Article  Google Scholar 

  20. Van den Berge G, de Zegher F, Bouillon R (1998) Acute and prolonged critical illness as different neuroendocrine paradigms. J Clin Endocrinol Metab 83:1827–1834. Medline. doi:10.1210/jc.83.6.1827

    Article  Google Scholar 

  21. Jarrell J, Franks S, McInnes R et al (1980) Breast examination does not elevate serum prolactin. Fertil Steril 33:49–51. Medline

    PubMed  CAS  Google Scholar 

  22. Casanueva FF, Molitch ME, Schlechte JA et al (2006) Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas. Clin Endocrinol (Oxf) 65:265–273. Medline. doi:10.1111/j.1365-2265.2006.02562.x

    Article  Google Scholar 

  23. Muneyyirci DO, Goldstein D, Reyes FI (1989) Diagnosis of stress-related hyperprolactinemia. Evaluation of the hyperprolactinemia rest test. N Y State J Med 89:205–208. Medline

    Google Scholar 

  24. Moli RL, Endert E, Fliers E et al (2003) Evaluation of endocrine tests. A: the TRH test in patients with hyperprolactinaemia. Neth J Med 71:44–48

    Google Scholar 

  25. Sawers HA, Robb OJ, Walmsley D (1997) An audit of the diagnostic usefulness of prolactin and TSH responses to domperidone and high resolution magnetic resonance imaging of the pituitary in the evaluation of hyperprolactinaemia. Clin Endocrinol (Oxf) 46:321–326. Medline. doi:10.1046/j.1365-2265.1997.1350956.x

    Article  CAS  Google Scholar 

  26. Kamoi T, Tchuchida I, Sata H et al (1981) Comparison of the responses in the nomifensine test with hyperprolactinemia due to prolactin-secreting pituitary tumors and nonprolactin-secreting hypothalamic tumors. J Clin Endocrinol Metab 53:1285–1287. Medline

    PubMed  CAS  Google Scholar 

  27. Archer DF, Josimovich JB, Maroon JC (1977) Chlorpromazine-induced changes in serum prolactin in women with oligomenorrhea, amenorrhea and pituitary adenoma. Fertil Steril 28:1164–1167. Medline

    PubMed  CAS  Google Scholar 

  28. Tucker HG, Lankford HV, Gardner DF et al (1980) Persistent defect in regulation of prolactin secretion after successful pituitary tumor removal in women with galactorrhea-amenorrhea syndrome. J Clin Endocrinol Metab 51:968–971. Medline

    PubMed  CAS  Google Scholar 

  29. Cowden EA, Thomsom JA, Doyle D et al (1979) Tests of prolactin secretion in diagnosis of prolactinomas. Lancet 320:1155–1158. doi:10.1016/S0140-6736(79)91841-5

    Article  Google Scholar 

  30. Molitch ME, Goodman RH, Post KD et al (1982) Surgical cure of prolactinoma reverses abnormal prolactin response to carbidopa/l-dopa. J Clin Endocrinol Metab 55:1118–1123. Medline

    PubMed  CAS  Google Scholar 

  31. Vance ML, Thorner MO (1987) Prolactinomas. Endocrinol Metab Clinics N Amer 16:731–753

    CAS  Google Scholar 

  32. St-Jean E, Blain F, Comtois R (1996) High prolactin levels may be missed by immunoradiometric assay in patients with macroprolactinomas. Clin Endocrinol (Oxf) 44:305–309. Medline. doi:10.1046/j.1365-2265.1996.663486.x

    Article  CAS  Google Scholar 

  33. Suh HK, Frantz AG (1974) Size heterogeneity of human prolactin in plasma and pituitary extracts. J Clin Endocrinol Metab 39:928–935. Medline

    PubMed  CAS  Google Scholar 

  34. Farkouh NH, Packer MG, Frantz AG (1979) Large molecular size prolactin with reduced receptor activity in human serum: high proportion in basal state and reduction after thyrotropin-releasing hormone. J Clin Endocrinol Metab 48:1026–1032. Medline

    PubMed  CAS  Google Scholar 

  35. Hattori N, Inagaki C (1997) Anti-prolactin autoantibodies cause asymptomatic hyperprolactinemia :bioassay and clearance studies of prolactin-immunoglobulin G complex. J Clin Endocrinol Metab 82:3107–3110. Medline. doi:10.1210/jc.82.9.3107

    PubMed  Article  CAS  Google Scholar 

  36. Fahie-Wilson M, Soule S (1997) Macroprolactinaemia: contribution to hyperprolactinaemia in a district general hospital and evaluation of a screening test based on precipitation with polyethylene glycol. Ann Clin Biochem 34:252–258, Medline

    PubMed  CAS  Google Scholar 

  37. Olukoga A, Kane J (1999) Macroprolactinaemia: validation and application of the polyethylene glycol precipitation test and clinical characterization of the condition. Clin Endocrinol (Oxf) 51:119–126. Medline. doi:10.1046/j.1365-2265.1999.00757.x

    Article  CAS  Google Scholar 

  38. Leslie H, Courtney C, Bell P et al (2001) A Laboratory and clinical experience in 55 patients with macroprolactinemia identified by a simple polyethylene glycol precipitation method. J Clin Endocrinol Metab 86:2743–2746. Medline. doi:10.1210/jc.86.6.2743

    PubMed  Article  CAS  Google Scholar 

  39. Vallette-Kasic S, Morange-Ramos I, Selim A et al (2002) Macroprolactinemia revisited: a study on 106 patients. J Clin Endocrinol Metab 587:581–588. doi:10.1210/jc.87.2.581

    Article  Google Scholar 

  40. Suliman AM, Smith TP, Gibney J et al (2003) Frequent misdiagnosis and mismanagement of hyperprolactinemic patients before the introduction of macroprolactin screening: application of a new strict laboratory definition of macroprolactinemia. Clin Chem 49:1504–1509. Medline. doi:10.1373/49.9.1504

    PubMed  Article  CAS  Google Scholar 

  41. Molitch ME, Russell EJ (1990) The pituitary ‘incidentaloma’. Ann Intern Med 112:925–931. Medline

    PubMed  CAS  Google Scholar 

  42. Smith TP, Suliman AM, Fahie-Wilson MN et al (2002) Gross variability in the detection of prolactin in sera containing big big prolactin (macroprolactin) by commercial immunoassays. J Clin Endocrinol Metab 87:5410–5415. Medline. doi:10.1210/jc.2001-011943

    PubMed  Article  CAS  Google Scholar 

  43. Pinto LP, Hanna FWF, Evans LM, Davies JS, John R, Scanlon MF (2003) The TSH response to domperidone reflects the biological activity of prolactin in macroprolactinaemia and hyperprolactinaemia. Clin Endocrinol (Oxf) 59:580–584. Medline. doi:10.1046/j.1365-2265.2003.01887.x

    Article  CAS  Google Scholar 

  44. Gibney J, Smith TP, McKenna TJ (2005) The impact on clinical practice of routine screening for macroprolactin. J Clin Endocrinol Metab 90:3927–3932. Medline. doi:10.1210/jc.2004-2234

    PubMed  Article  CAS  Google Scholar 

  45. David SR, Taylor CC, Kinon BJ (2000) The effects of olanzapine, risperidone, and haloperidol on plasma prolactin levels in patients with schizophrenia. Clin Ther 22:1085–1096. Medline. doi:10.1016/S0149-2918(00)80086-7

    PubMed  Article  CAS  Google Scholar 

  46. Molitch M (2005) Medication-induced hyperprolactinemia. Mayo Clin Proc 80:1050–1057 Medline

    PubMed  Google Scholar 

  47. Lim VS, Kathpalia S, Frohman LA (1979) Hyperprolactinemia and impaired pituitary response to suppression and stimulation in chronic renal failure: reversal after transplantation. J Clin Endocrinol Metab 48:101–107 Medline

    PubMed  CAS  Google Scholar 

  48. Honbo KS, Herle AJV, Kellett KA (1978) Serum prolactin levels in untreated primary hypothyroidism. Am J Med 64:782–787. Medline. doi:10.1016/0002-9343(78)90517-X

    PubMed  Article  CAS  Google Scholar 

  49. Frank S (1995) Polycystic ovary syndrome. N Engl J Med 333:853–861. Medline. doi:10.1056/NEJM199509283331307

    Article  Google Scholar 

  50. Hilho RB, Domingues L, Naves L, Ferraz E, Alves A, Casulari LA (2007) Polycystic ovary syndrome and hyperprolactinemia are distinct entities. Gynecol Endocrinol 23:267–272. Medline. doi:10.1080/09513590701297708

    Article  CAS  Google Scholar 

  51. Morgan MY, Jakobovits AW, Gore MB et al (1978) Serum prolactin in liver disease and its relationship to gynecomastia. Gut 19:170–174. Medline. doi:10.1136/gut.19.3.170

    PubMed  Article  CAS  Google Scholar 

  52. Serri O, Chik CL, Ur E et al (2003) Diagnosis and management of hyperprolactinemia. CMAJ 169:575–581. Medline

    PubMed  Google Scholar 

  53. Schlechte JA (2003) Prolactinoma. N Engl J Med 349:2035–2041. Medline. doi:10.1056/NEJMcp025334

    PubMed  Article  CAS  Google Scholar 

  54. Arafah MB, Nekl KE, Gold RS et al (1995) Dynamics of prolactin secretion in patients with hypopituitarism and pituitary macroadenomas. J Clin Endocrinol Metab 80:3507–3512. Medline. doi:10.1210/jc.80.12.3507

    PubMed  Article  CAS  Google Scholar 

  55. Karavitaki Ni Thanabalasingham G, Shore HCA, Trifanescu R, Ansorge O, Meston N, Turner H, Wass JAH (2006) Do the limits of serum prolactin in disconnection hyperprolactinemia need re-definition? A study of 226 patients with histologically verified non-functioning pituitary macroadenoma. Clin Endocrinol (Oxf) 65:524–529. Medline. doi:10.1111/j.1365-2265.2006.02627.x

    Article  CAS  Google Scholar 

  56. Schlechte J, Dolan K, Sherman B et al (1989) The natural history of untreated hyperprolactinemia; a prospective analysis. J Clin Endocrinol Metab 68:412–418. Medline

    PubMed  CAS  Article  Google Scholar 

  57. Verhelst J, Abs R (2003) Hyperprolactinemia: pathophysiology and management. Treat Endocrinol 2:23–32. Medline. doi:10.2165/00024677-200302010-00003

    PubMed  Article  Google Scholar 

  58. Kauppila A, Chatelaiin P, Kirkinen P (1987) Isolated prolactin deficiency in a woman with puerperal alactogenesis. J Clin Endocrinol Metab 64:309–312. Medline

    PubMed  CAS  Google Scholar 

  59. Saito T, Tojo K, Sakamoto N et al (2007) A case of prolactin deficiency with familial puerperal alactogenesis accompanying impaired ACTH secretion. Endocr J 54:59–62. Medline. doi:10.1507/endocrj.K05-163

    PubMed  Article  CAS  Google Scholar 

  60. Toledano Y, Lubetsky A, Shimon I (2007) Acquired prolactin deficiency in patients with disorders of the hypothalamic-pituitary axis. J Endocrinol Invest 30:268–273. Medline

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Janet Schlechte.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Chahal, J., Schlechte, J. Hyperprolactinemia. Pituitary 11, 141 (2008). https://doi.org/10.1007/s11102-008-0107-5

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11102-008-0107-5

Keywords

  • Prolactin
  • Pituitary tumor
  • Hook effect
  • Macroprolactin